King & Spalding continues hiring spree from pre-merged Winston
The latest additions bring experience representing technology and medical device companies in complex patent and commercial disputes, with the firm extending its run of bringing in partners from Winston & Strawn before its merger.
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Atif Choudhury at achoudhury@lifesciencesipreview.com
27 October 2026 The departing partners bring expertise across molecular biology, biochemistry, small molecule and peptide drugs, including blockbuster therapies, as well as chemical and mechanical technologies.
21 October 2026 With specialisms covering AI, electrical, manufacturing and engineering, the pair move from Brownstein, following a former colleague who joined the firm earlier this year.
14 October 2026 Growing demand from life sciences and healthcare clients prompts an expansion in California, bringing the firm closer to biotechnology companies, research institutions and key courts for its Southern California litigators.